1. Contractors
  2. Osivax

Osivax

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Osivax has 2 federal contracts of $100,000 or more active since October 2023, with $20.2M obligated, from 1 agency. 2 are still running, 1 ending within 18 months.

Contracts
2 since FY2024$20,229,361 obligated, contracts of $100,000 or more
Running now
2 contracts
Biggest customer
Office of Assistant Secretary for Preparedness and Response$20.2M on 2 contracts
UEI
M4YDKJJRJYC7Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Oxivax - Aoi #28: Influenza Vaccine Innovation. Advancing Metagenomic Next-Generation Sequencing Based Agnostic Diagnostics for Viral Pathogens the Overall Objective of This Contract Is to Prepare…Office of Assistant Secretary for Preparedness and Response · 75A50125C00006$743,969Mar 31, 2027in 4 monthsNot stated
Osivax - Clinical Proof of Concept of OVX836, a Single-Shot Broadly Protective Influenza a Vaccine for Immediate Protection Against Emerging Pandemic StrainsOffice of Assistant Secretary for Preparedness and Response · 75A50125C00008$19,485,392Jul 24, 2028in 20 monthsNot stated

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
Office of Assistant Secretary for Preparedness and Response2 contracts$20,229,361

What they sell

IndustryAmount
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 2 contracts$20,229,361

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.

Get new notices like Osivax's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy